New Nanosystem Offers Precision Targeting and Therapy for Tongue Cancer
Researchers have developed a new nanosystem that provides precision targeting and therapy for tongue cancer, potentially improving treatment outcomes.
Disrupting the RBM42 protein could throw a wrench in the gears of cancer’s growth
For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many cancers manage to overcome this and continue growing. Now, UCSF scientists think they can throw a wrench into the fabrication of a key growth-related protein, MYC, that escalates wildly in 70% of all cancers. Unlike some other targets of cancer therapies, MYC can be dangerous simply due to its abundance.
Cancer Treatment Kills Tumors Using Sound And Water
In what medical experts are calling a potential game-changer, a new FDA-approved treatment uses highly-focused soundwaves to destroy cancer cells. This innovative approach, known as histotripsy, offers several advantages over traditional radiation and radiofrequency ablation treatments, providing hope for patients with limited options.
Metastatic cancers: Targeting a protein that fuels treatment-resistant tumors may be key to better outcomes
One of the biggest challenges in cancer treatment is addressing the ability of cancer cells to adapt and become resistant, reducing the effectiveness of therapies over time.
How scientists redesigned an effective cancer therapy to make it safer
University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the new drug may be tolerated by a broader range of leukemia patients and even be used to treat other cancers.
New Insights into Cancer Treatment Emerge
Recent studies have provided new insights into cancer treatment, potentially paving the way for more effective therapies.
Roche’s Itovebi Rivals Novartis and AZ, Bolsters Its Benefits Profile with Overall Survival Win
Roche’s cancer drug Itovebi has demonstrated improved overall survival rates, positioning it as a strong competitor against treatments from Novartis and AstraZeneca.
Navigating nutrition during cancer treatment: A dietitian's advice
During cancer treatment, our bodies require optimal nourishment, so eating well is especially important. Unfortunately, the treatments themselves—including chemotherapy and radiation—can interfere with appetite and digestion, making it harder to consistently eat healthy foods or even eat much at all. Filling your fridge and pantry with a variety of foods before treatment begins and being […]
Study highlights new target and potential therapy for treatment-resistant cancers
University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant cancers by targeting a specific protein modification, according to a study published in the International Journal of Biological Sciences.
From COVID-19 testing to a breakthrough in cancer treatment monitoring
Innovations originally developed for COVID-19 testing are now being applied to monitor cancer treatments more effectively.
Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy regimen, according to results from the Phase III BREAKWATER trial led by researchers at The University of Texas MD Anderson Cancer Center.
Researchers find a way to stop harmful cells after cancer treatment
Researchers from the University of Barcelona describe a mechanism for eliminating harmful cells from cancer treatment
